|
TPX2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.18789480661053E-12 |
| Normal-vs-Stage2 |
6.08149999999918E-05 |
| Normal-vs-Stage3 |
9.77480000274866E-08 |
| Normal-vs-Stage4 |
1.73370000022821E-07 |
| Stage1-vs-Stage2 |
5.329000E-01 |
| Stage1-vs-Stage3 |
1.983520E-02 |
| Stage1-vs-Stage4 |
3.550700E-04 |
| Stage2-vs-Stage3 |
1.586400E-01 |
| Stage2-vs-Stage4 |
2.243100E-03 |
| Stage3-vs-Stage4 |
3.470300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
7.403700E-04 |
| Normal-vs-Asian |
1.579760E-01 |
| Caucasian-vs-AfricanAmerican |
6.942400E-03 |
| Caucasian-vs-Asian |
5.675800E-01 |
| AfricanAmerican-vs-Asian |
3.353400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.99680288865056E-15 |
| Normal-vs-Female |
4.03166389162379E-12 |
| Male-vs-Female |
1.877640E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.141000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.99910096757117E-11 |
| Normal-vs-Age(61-80Yrs) |
3.38584715819934E-12 |
| Normal-vs-Age(81-100Yrs) |
2.460600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.944390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.941800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.931500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.319600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.156200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.145840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.398800E-04 |
| Normal-vs-Grade 2 |
7.00328683933549E-13 |
| Normal-vs-Grade 3 |
7.14228676201856E-12 |
| Normal-vs-Grade 4 |
5.30779999952102E-07 |
| Grade 1-vs-Grade 2 |
1.797670E-03 |
| Grade 1-vs-Grade 3 |
1.67355999999286E-05 |
| Grade 1-vs-Grade 4 |
3.6105000000064E-05 |
| Grade 2-vs-Grade 3 |
8.603400E-03 |
| Grade 2-vs-Grade 4 |
3.248400E-04 |
| Grade 3-vs-Grade 4 |
5.280400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.1017998452777E-10 |
| Normal-vs-ccB subtype |
4.24679957866658E-10 |
| ccA subtype-vs-ccB subtype |
1.018950E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.29634147439629E-12 |
| Normal-vs-N1 |
1.022640E-03 |
| N0-vs-N1 |
2.032400E-02 |
|
|
